Eugene T. Grygielko

Publications by Year

Research Areas

Estrogen and related hormone effects, TGF-β signaling in diseases, Renin-Angiotensin System Studies, Endometriosis Research and Treatment, Coagulation, Bradykinin, Polyphosphates, and Angioedema

Most-Cited Works

• → Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542(2002)647 cited
• → Oral administration of GW788388, an inhibitor of TGF-β type I and II receptor kinases, decreases renal fibrosis(2007)214 cited
• → Inhibition of Gene Markers of Fibrosis with a Novel Inhibitor of Transforming Growth Factor-β Type I Receptor Kinase in Puromycin-Induced Nephritis(2005)186 cited
• → Novel Rho Kinase Inhibitors with Anti-inflammatory and Vasodilatory Activities(2006)156 cited
• → Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype(2013)151 cited
• → A Structural and in Vitro Characterization of Asoprisnil: A Selective Progesterone Receptor Modulator(2007)148 cited
• → Discovery of 4-{4-[3-(Pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl}-N-(tetrahydro-2H- pyran-4-yl)benzamide (GW788388): A Potent, Selective, and Orally Active Transforming Growth Factor-β Type I Receptor Inhibitor(2006)102 cited
• → Osmolality: a physiological long-term regulator of lumbar sympathetic nerve activity and arterial pressure(1999)69 cited
• → Inhibition of ALK5 Signaling Induces Physeal Dysplasia in Rats(2007)47 cited
• → Estrogen-induced stromal cell-derived factor-1 (SDF-1/Cxcl12) expression is repressed by progesterone and by Selective Estrogen Receptor Modulators via estrogen receptor α in rat uterine cells and tissues(2009)37 cited